127 related articles for article (PubMed ID: 33590552)
1. Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.
Yang J; Wei R; Song X; Sun X; Wang H; Liu Q; Hu L; Yu H; Wang D
Head Neck; 2021 Jun; 43(6):1769-1779. PubMed ID: 33590552
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.
Lan LF; Gao CK; Ma CW
Otolaryngol Head Neck Surg; 2021 Feb; 164(2):359-368. PubMed ID: 32692284
[TBL] [Abstract][Full Text] [Related]
3. Minor Salivary Gland Cancer of the Head and Neck: A Review of Epidemiologic Aspects, Prognostic Factors, and Outcomes.
Moretz-Sohn PF; Dias FL; de Carvalho Marques CM
Curr Oncol Rep; 2023 Mar; 25(3):173-179. PubMed ID: 36705878
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
Marti JL; Jain KS; Morris LG
Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
[TBL] [Abstract][Full Text] [Related]
5. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
Wang W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and risk of second primary malignancies after radiotherapy in major salivary gland carcinomas: A retrospective study using SEER database.
Feng Y; Qian K; Guo K; Shi Y; Zhou J; Wang Z
Head Neck; 2024 May; 46(5):1201-1209. PubMed ID: 38284127
[TBL] [Abstract][Full Text] [Related]
7. Second primaries after major salivary gland cancer.
Megwalu UC; Shin EJ
Otolaryngol Head Neck Surg; 2011 Aug; 145(2):254-8. PubMed ID: 21493280
[TBL] [Abstract][Full Text] [Related]
8. The risk and prognosis of secondary primary malignancy in lung cancer: a population-based study.
Hong J; Wei R; Nie C; Leonteva A; Han X; Du X; Wang J; Zhu L; Tian W; Zhou H
Future Oncol; 2021 Nov; 17(33):4497-4509. PubMed ID: 34402680
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of primary tumor surgery in minor salivary-gland carcinoma patients with distant metastases at diagnosis: first evidence from a SEER-based study.
Shi X; Huang NS; Shi RL; Wei WJ; Wang YL; Ji QH
Cancer Manag Res; 2018; 10():2163-2172. PubMed ID: 30050326
[TBL] [Abstract][Full Text] [Related]
10. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
Khanal A; Budhathoki N; Singh VP; Shah BK
Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
[TBL] [Abstract][Full Text] [Related]
11. Five- and 10-Year Cause-Specific Survival Rates in Carcinoma of the Minor Salivary Gland.
Baddour HM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):67-73. PubMed ID: 26632951
[TBL] [Abstract][Full Text] [Related]
12. Minor Salivary Gland Carcinoma of the Oropharynx: A Population-Based Analysis of 1426 Patients.
Goel AN; Badran KW; Braun APG; Garrett AM; Long JL
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):287-294. PubMed ID: 28971745
[TBL] [Abstract][Full Text] [Related]
13. Risk and survival of second primary malignancies following diagnosis of gastric mucosa-associated lymphoid tissue lymphomas: A population-based study.
Yang Y; Yang Y; Yan S
Curr Probl Cancer; 2021 Dec; 45(6):100735. PubMed ID: 33867153
[TBL] [Abstract][Full Text] [Related]
14. Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer.
Yesensky J; Kyrillos A; Kuchta K; Yao K; Wang CH; Bhayani MK
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):303-308. PubMed ID: 29039234
[TBL] [Abstract][Full Text] [Related]
15. Impact of latency time on survival for adolescents and young adults with a second primary malignancy.
Goldfarb M; Rosenberg AS; Li Q; Keegan THM
Cancer; 2018 Mar; 124(6):1260-1268. PubMed ID: 29205296
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of salivary gland cancer among women with a previous cancer diagnosis.
Falchook AD; Zevallos JP; Chera BS
Head Neck; 2016 Apr; 38 Suppl 1():E446-51. PubMed ID: 25581457
[TBL] [Abstract][Full Text] [Related]
17. Second primary malignancies in patients with melanoma in situ: Insights from the surveillance, epidemiology, and end results program.
Ulanja MB; Beutler BD; Antwi-Amoabeng D; Cohen PR; Moody AE; Rahman GA; Djankpa FT; Gullapalli N; Boampong-Konam K; Macaire JK; Bowman AT; Baral S; Bowles DW
Cancer Epidemiol; 2021 Jun; 72():101932. PubMed ID: 33773145
[TBL] [Abstract][Full Text] [Related]
18. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
19. Primary diffuse large B-cell lymphoma of the major salivary glands: Increasing incidence and survival.
Gupta A; Lee JA; Nguyen SA; Lentsch EJ
Am J Otolaryngol; 2021; 42(3):102938. PubMed ID: 33524741
[TBL] [Abstract][Full Text] [Related]
20. Better survival and prognosis in SCLC survivors after combined second primary malignancies: A SEER database-based study.
Wang S; Hu S; Huang S; Su L; Guo Q; Wu B; Ye J; Zhang D; Zhang Y; Zhang W; Wei Y
Medicine (Baltimore); 2023 Feb; 102(6):e32772. PubMed ID: 36820587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
